Allogeneic CD19-targeted CAR-T therapy in patients with severe myositis and systemic sclerosis

已完结 10 由 aiqujie 发布于 2024/10/22 15:49:20

DOI:10.1016/j.cell.2024.06.027
文献类型：期刊论文
补充材料：只需要正文

Elsevier

Abstract：Allogeneic chimeric antigen receptor (CAR)-T cells hold great promise for expanding the accessibility of CAR-T therapy, whereas the risks of allograft rejection have hampered its application

应助信息

13小时前

Book学术机器人

fffab7088b5a11ef825e34735aa3bc31.pdf 已采纳

13小时前

Book学术机器人

2024/10/22 15:49:20 Book学术AI机器人已找到文献并上传

2024/10/22 15:49:20 Book学术AI机器人收到请求，开始寻找文献

2024/10/22 15:49:20 已向机器人发送请求

13小时前

aiqujie 发布求助

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:New England Journal of Medicine (NEJM)CD19 CAR T-Cell Therapy in Autoimmune Disease — A Case Series with Follow-up